UBS Group’s AEON Biopharma Inc AEON.WS Stock Holding History

UBS Group’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,900	Closed	-$7.11K	–	10420
2024 Q1	$7.11K	Buy	4,900 +4,010	+451%	+$2.46K	﹤0.01%	7412
2023 Q4	$67	Buy	+890	New	+$66	﹤0.01%	8961
2023 Q1	–	Sell	-1,300	Closed	-$65	–	10812
2022 Q4	$65	Sell	1,300 -501	-28%	-$20	﹤0.01%	10454
2022 Q3	$0	Hold	1,801	–	–	﹤0.01%	11211
2022 Q2	$0	Hold	1,801	–	–	﹤0.01%	11217
2022 Q1	$1K	Hold	1,801	–	–	﹤0.01%	9987
2021 Q4	$1K	Sell	1,801 -899	-33%	-$497	﹤0.01%	10075
2021 Q3	$2K	Hold	2,700	–	–	﹤0.01%	9021
2021 Q2	$3K	Buy	+2,700	New	+$2.05K	﹤0.01%	8861

UBS Group's AEON.WS Position: Q2 2024 in Review

UBS Group sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 4,900 shares — an estimated $7.11K sold.

UBS Group first reported a position in AEON.WS in Q2 2021 and held it in 9 quarters. The position peaked at $7.11K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

UBS Group reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
UBS Group sold 4,900 AEON Biopharma Inc shares in Q2 2024, an estimated $7.11K.
UBS Group first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 9 quarters.
UBS Group's AEON Biopharma Inc position peaked at $7.11K in Q1 2024.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.